Anna Schölin

724 total citations
9 papers, 577 citations indexed

About

Anna Schölin is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Anna Schölin has authored 9 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Genetics and 6 papers in Surgery. Recurrent topics in Anna Schölin's work include Diabetes and associated disorders (7 papers), Diabetes Management and Research (7 papers) and Pancreatic function and diabetes (6 papers). Anna Schölin is often cited by papers focused on Diabetes and associated disorders (7 papers), Diabetes Management and Research (7 papers) and Pancreatic function and diabetes (6 papers). Anna Schölin collaborates with scholars based in Sweden, India and United States. Anna Schölin's co-authors include Jan Bolinder, Hans J. Arnqvist, G. Blohmé, Jan W. Eriksson, L. Nyström, Jan‐Ola Östman, Soffia Guðbjörnsdóttir, G. Sundkvist, G. Sundkvist and Christian Berne and has published in prestigious journals such as Diabetes Care, Diabetologia and Journal of Internal Medicine.

In The Last Decade

Anna Schölin

9 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Schölin Sweden	8	267	260	193	183	87	9	577
Minerva Granado-Casas Spain	13	53 0.2×	186 0.7×	76 0.4×	54 0.3×	28 0.3×	35	448
Elżbieta Bandurska‐Stankiewicz Poland	11	81 0.3×	222 0.9×	43 0.2×	83 0.5×	12 0.1×	52	426
Claudia Piona Italy	16	212 0.8×	357 1.4×	49 0.3×	243 1.3×	24 0.3×	59	569
Hanna Dis Margeirsdottir Norway	14	222 0.8×	509 2.0×	23 0.1×	154 0.8×	21 0.2×	25	763
Bedowra Zabeen Bangladesh	12	209 0.8×	355 1.4×	12 0.1×	155 0.8×	24 0.3×	41	622
Daria Maggi Italy	11	141 0.5×	165 0.6×	134 0.7×	174 1.0×	107 1.2×	21	498
A. Sämann Germany	15	173 0.6×	446 1.7×	25 0.1×	129 0.7×	15 0.2×	26	754
Ghada M. Anwar Egypt	12	67 0.3×	129 0.5×	23 0.1×	66 0.4×	25 0.3×	30	413
R.N. Dalton United Kingdom	10	118 0.4×	184 0.7×	14 0.1×	98 0.5×	6 0.1×	17	515
Hernando Vargas‐Uricoechea Colombia	13	74 0.3×	349 1.3×	49 0.3×	105 0.6×	30 0.3×	52	568

Countries citing papers authored by Anna Schölin

Since Specialization

Citations

This map shows the geographic impact of Anna Schölin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Schölin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Schölin more than expected).

Fields of papers citing papers by Anna Schölin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Schölin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Schölin. The network helps show where Anna Schölin may publish in the future.

Co-authorship network of co-authors of Anna Schölin

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Schölin. A scholar is included among the top collaborators of Anna Schölin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Schölin. Anna Schölin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Schölin, Anna, L. Nyström, Hans J. Arnqvist, et al.. (2010). Proinsulin/C‐peptide ratio, glucagon and remission in new‐onset Type 1 diabetes mellitus in young adults. Diabetic Medicine. 28(2). 156–161. 33 indexed citations

Frykman, Jonas, et al.. (2007). DISCRIMINATION – A THREAT TO PUBLIC HEALTH Final report – Health and Discrimination Project. Digital Repository at the University of Maryland (University of Maryland College Park). 6 indexed citations

Littorin, Bengt, Anna Schölin, Hans J. Arnqvist, et al.. (2006). Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia. 49(12). 2847–2852. 227 indexed citations

Schölin, Anna, Agneta Siegbahn, Lars Lind, et al.. (2004). CRP and IL‐6 concentrations are associated with poor glycemic control despite preserved β‐cell function during the first year after diagnosis of type 1 diabetes. Diabetes/Metabolism Research and Reviews. 20(3). 205–210. 34 indexed citations

Schölin, Anna, Carina Törn, L. Nyström, et al.. (2004). Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes. Diabetic Medicine. 21(5). 447–455. 32 indexed citations

Schölin, Anna, Henrik Borg, Hans J. Arnqvist, et al.. (2004). Islet antibodies and remaining β‐cell function 8 years after diagnosis of diabetes in young adults: a prospective follow‐up of the nationwide Diabetes Incidence Study in Sweden. Journal of Internal Medicine. 255(3). 384–391. 43 indexed citations

Henricsson, Marianne, Lennarth Nyström, G. Blohmé, et al.. (2003). The Incidence of Retinopathy 10 Years After Diagnosis in Young Adult People With Diabetes. Diabetes Care. 26(2). 349–354. 139 indexed citations

Karlsson, F. Anders, et al.. (2000). Beta-cell Activity and Destruction in Type 1 Diabetes. Upsala Journal of Medical Sciences. 105(2). 85–95. 17 indexed citations

Schölin, Anna, Christian Berne, E. Schvarcz, F. Anders Karlsson, & Erik Björk. (1999). Factors predicting clinical remission in adult patients with type 1 diabetes. Journal of Internal Medicine. 245(2). 155–162. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact